Mental deterioration occurring in old age, usually termed senile dementia, is one of the most common, yet most poorly understood of neurological conditions. A great number of the early and, indeed, the recent studies (Dayan, 1970; Tomlinson et al., 1970; Colon, 1973; Gibson et al., 1976 ) have attempted to evaluate its pathogenesis and severity in terms of the most obvious neuropathological findings-namely, senile plaques and neurofibrillary tangles-but as yet the relevance of these features to the underlying mechanism remains uncertain.
Other studies have taken a more biochemical viewpoint. Reports by co-workers (1969, 1974) , and Fisher (1972) , have indicated a generalised disturbance of monoamine metabolism in the brains of patients suffering from senile dementia. Other reports have implied that accumulation within neurones of lipoprotein pigments may play a significant role in the disease process. Gedye et al. (1972) noted that treatment of some patients suffering from organic dementia with meclofenoxate (Lucidril) improved intellectual function; meclofenoxate has been shown (Nandy, 1968; Spoerri and Glees, 1974) (Shea, 1970) .
Measurements of nerve cell RNA content were made, as detailed elsewhere (Mann and Yates, 1974; Mann et al., 1976) 
Results
Results of overall mean cell RNA content derived for each neurone group from 10 demented patients and 15 normal control subjects of similar age range are shown in the Table. The difference in overall mean cell RNA content between the demented and the control groups exceeds the 5% level of significance in all groups of neurones studied and the 0.1 % level in most cases. These differences are expressed in the Table as mean percentage losses of cell RNA from neurones of the demented group.
As argued earlier (Mann and Yates, 1974) , it is appropriate to use the amount of cell RNA as an Nandy (1968) demonstrated that this compound could bring about a reduction in lipofuscin in cerebral nerve cells of experimental animals. These studies infer that lipoprotein pigments may play some part in the disease process. It may, therefore, be argued that in senile dementia, the measured RNA losses could come about because of increased levels of pigmentation. However, it has been shown (Mann and Sinclair, 1977) that there is no significant difference in mean pigment levels between a demented and a non-demented control group of patients, of similar age range, for cells of the inferior olivary nucleus and pyramidal cells of the hippocampus. Both groups of patients show pigment accumulation appropriate to their age. Therefore, despite the observations of Nandy (1968) , and Spoerri and Glees (1974) , that meclofenoxate beneficially reduces lipofuscin levels in nerve cells, it seems unlikely that pigment removal, per se, has any bearing on the im-provement in intellectual function reported by Gedye et al. (1972) after treatment with the drug.
Other authors have reported disturbances in catecholamine metabolism in brains of patients suffering from senile dementia. Gottfries et al. (1969 Gottfries et al. ( , 1974 measured reduced CSF levels of homovanillic acid (HVA), and 5 hydroxyindoleacetic acid (HIAA), the major breakdown products of dopamine and 5-hydroxytryptamine (5HT) respectively. Furthermore, Fisher (1972) measured reduced levels of HVA but no decrease in 4-hydroxy-3-methoxy mandelic acid (VMA), the major noradrenaline metabolite, in the urine of demented patients. In our study, neurones of the substantia nigra were shown to have lost, on average, some 13 % cell RNA. Thus, the findings of reduced levels of HVA in CSF and urine, indicative of a reduction in dopamine metabolism, taken in conjunction with that of RNA loss, suggest a decreased activity, though not necessarily a dysfunction of neurones of the substantia nigra. Similarly, the widespread reduction in HIAA, indicative of a general disturbance in 5HT metabolism, can be related to the general loss of RNA seen in cells of the cerebral cortex.
Noradrenaline bearing neurones are restricted, within the CNS, to cells of the locus caeruleus (Olson and Fuxe, 1971; Ungerstedt, 1971; Kobayashi et al., 1974) , and thus constitute only a tiny proportion of the total number of noradrenaline cells in the body. It is hardly to be expected that changes in noradrenaline metabolism in the locus caeruleus would be reflected in changes in urinary VMA. Cells of the locus caeruleus have been shown to give rise to pathways innervating the hippocampus and all cortical areas (Ungerstedt, 1971; Kobayashi et al., 1974) , cerebellum (Olson and Fuxe, 1971 ; Ungerstedt, 1971; Kobayashi et al., 1974) , and certain nuclei of the thalamus and hypothalamus (Kobayashi et al., 1974) . Through these pathways the locus caeruleus is thought to influence the level of activity of these higher cortical areas (Olson and Fuxe, 1971) , and thus indirectly, the whole of the CNS. Lesions in the locus caeruleus, resulting in reduced catecholamine output, would, therefore, be expected to cause a decline in neurological activity throughout the brain, possibly reflected in the widespread loss of RNA in neurones of demented patients that we have observed.
Our studies show that cells of the locus caeruleus have lost, on average, only some 9 % RNA, and such a figure does not appear to suggest a substantial reduction in noradrenaline metabolism in these neurones; however, it cannot be ruled out altogether. We have shown that greatest losses of RNA occur in pyramidal cells of areas h2-h5 of Ammon's horn in the hippocampus (Table) . Tomlinson and Kitchener (1972) found that, in senile dementia, these cells were more severely affected by granulovacuolar degeneration than in a control group of non-demented persons of similar age range, and that in most cases, this change was restricted to this cell type. It is likely, therefore, that the higher loss of RNA we have measured in these cells is related to the presence and severity of this type of degeneration.
The relationship of these lesions in the hippocampus to dementia is not clear. It is known that patients suffering from senile dementia show severe memory defects, especially for recent events and for the assimilation of fresh information (Kral, 1972; Miller, 1973) , while long-term recall is relatively unaffected. Furthermore, non-demented patients who have displayed serious memory disturbances typical of senile dementia have, at necropsy, shown severe loss of pyramidal cells of the hippocampus (Victor et al., 1961 
